[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

KRON Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 23.40%

Insider Buying (Last 12 Months): $1,202,320.20

Insider Selling (Last 12 Months): $141,997.50

Kronos Bio Insider Trading History Chart

Kronos Bio Share Price & Price History

^$1.18

▼ -0.05 (-4.07%)

As of 11/29/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Kronos Bio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/17/2023	Norbert W. Bischofberger	CEO	Buy	97,935	$1.08	$105,769.80	2,540,665
11/15/2023	Norbert W. Bischofberger	CEO	Buy	1,370,688	$0.80	$1,096,550.40	2,180,297
7/6/2023	Christopher Dinsmore	Insider	Sell	6,634	$1.75	$11,609.50	278,367
7/6/2023	Jorge DiMartino	VP	Sell	10,818	$1.75	$18,931.50	344,622
7/6/2023	Yasir B Al-Wakeel	CFO	Sell	9,617	$1.75	$16,829.75	346,102
2/24/2023	Christopher Dinsmore	Insider	Sell	6,291	$1.74	$10,946.34	285,001
2/24/2023	Jorge DiMartino	VP	Sell	10,153	$1.74	$17,666.22	355,440
2/24/2023	Yasir B Al-Wakeel	CFO	Sell	9,026	$1.74	$15,705.24	355,719
12/12/2022	Christopher Dinsmore	Insider	Sell	9,138	$1.81	$16,539.78	162,936
12/12/2022	Jorge DiMartino	VP	Sell	18,657	$1.81	$33,769.17	219,478
5/19/2022	Norbert W. Bischofberger	CEO	Buy	300,000	$3.78	$1,134,000.00	809,609
5/17/2022	Norbert W. Bischofberger	CEO	Buy	90,931	$3.83	$348,265.73	303,411
12/13/2021	Christopher Dinsmore	Insider	Sell	11,386	$12.37	$140,844.82
12/13/2021	Jorge DiMartino	VP	Sell	16,402	$12.37	$202,892.74
12/6/2021	Norbert W. Bischofberger	CEO	Buy	14,356	$12.09	$173,564.04
12/1/2021	Marianne De Backer	Director	Buy	1,150	$11.57	$13,305.50
10/4/2021	Christopher Dinsmore	Insider	Sell	9,189	$20.81	$191,223.09
9/7/2021	Christopher Dinsmore	Insider	Sell	9,189	$21.91	$201,330.99	105,549
8/20/2021	Marianne De Backer	Director	Buy	1,000	$19.57	$19,570.00	1,100
8/2/2021	Christopher Dinsmore	Insider	Sell	9,189	$20.59	$189,201.51	105,549
5/28/2021	Marianne De Backer	Director	Buy	600	$25.01	$15,006.00	600
4/19/2021	Jakob Loven	Director	Sell	14,004	$20.59	$288,342.36
4/16/2021	Jakob Loven	Director	Sell	33,162	$21.01	$696,733.62
4/14/2021	Jakob Loven	Director	Sell	32,636	$22.80	$744,100.80
4/12/2021	Jakob Loven	Director	Sell	15,828	$26.28	$415,959.84
4/8/2021	Jakob Loven	Director	Sell	63,128	$27.41	$1,730,338.48

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Kronos Bio (NASDAQ:KRON)

54.68% of Kronos Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Kronos Bio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	GSA Capital Partners LLP	54,521	$71K	0.0%	-80.9%	0.093%
11/15/2023	Acuta Capital Partners LLC	718,739	$0.93M	0.6%	+128.2%	1.232%
11/13/2023	Acadian Asset Management LLC	614,945	$0.80M	0.0%	+6.4%	1.054%
9/21/2023	Barclays PLC	16,128	$28K	0.0%	-59.4%	0.028%
8/15/2023	XTX Topco Ltd	21,780	$37K	0.0%	N/A	0.037%
8/15/2023	Y Intercept Hong Kong Ltd	57,952	$100K	0.0%	N/A	0.099%
8/15/2023	Goldman Sachs Group Inc.	34,825	$60K	0.0%	-82.3%	0.060%
8/15/2023	Kennedy Capital Management LLC	106,496	$0.18M	0.0%	+564.6%	0.183%
8/15/2023	BVF Inc. IL	2,813,485	$4.84M	0.1%	N/A	4.824%
8/15/2023	Citadel Advisors LLC	214,496	$0.37M	0.0%	+126.1%	0.368%
8/14/2023	Marshall Wace LLP	126,309	$0.22M	0.0%	-32.9%	0.217%
8/14/2023	State of Wisconsin Investment Board	63,900	$0.11M	0.0%	-38.0%	0.110%
8/14/2023	State Street Corp	178,301	$0.31M	0.0%	-77.1%	0.306%
8/14/2023	Partners Capital Investment Group LLP	1,665,797	$2.87M	0.1%	+215.8%	2.856%
8/11/2023	Renaissance Technologies LLC	1,197,300	$2.06M	0.0%	+29.5%	2.053%
8/11/2023	BlackRock Inc.	1,397,345	$2.40M	0.0%	-55.6%	2.396%
8/11/2023	Geode Capital Management LLC	398,712	$0.69M	0.0%	-48.1%	0.684%
8/11/2023	JPMorgan Chase & Co.	67,968	$0.12M	0.0%	-97.5%	0.117%
8/11/2023	Northern Trust Corp	93,620	$0.16M	0.0%	-73.3%	0.161%
8/10/2023	Charles Schwab Investment Management Inc.	243,716	$0.42M	0.0%	-22.9%	0.423%
8/7/2023	Acadian Asset Management LLC	578,036	$0.99M	0.0%	+21.4%	1.003%
8/4/2023	CM Management LLC	250,000	$0.43M	0.4%	+38.9%	0.434%
8/3/2023	Barclays PLC	16,128	$28K	0.0%	-59.4%	0.028%
8/3/2023	Bank of New York Mellon Corp	16,618	$29K	0.0%	-87.4%	0.029%
7/28/2023	Marquette Asset Management LLC	68,041	$0.12M	0.0%	+40.1%	0.118%
7/26/2023	Privium Fund Management B.V.	292,182	$0.49M	0.1%	N/A	0.507%
5/22/2023	Ameriprise Financial Inc.	133,015	$0.19M	0.0%	+38.8%	0.231%
5/18/2023	JPMorgan Chase & Co.	2,742,201	$4M	0.0%	+6.7%	4.758%
5/16/2023	Susquehanna International Group LLP	126,783	$0.19M	0.0%	+254.9%	0.220%
5/16/2023	State Street Corp	779,403	$1.14M	0.0%	+6.6%	1.352%
5/16/2023	Squarepoint Ops LLC	46,088	$67K	0.0%	+52.5%	0.080%
5/16/2023	Geode Capital Management LLC	768,599	$1.12M	0.0%	+3.5%	1.334%
5/15/2023	Two Sigma Advisers LP	248,200	$0.36M	0.0%	-2.5%	0.431%
5/15/2023	Two Sigma Investments LP	161,642	$0.24M	0.0%	-17.0%	0.280%
5/15/2023	Deutsche Bank AG	49,447	$72K	0.0%	-57.7%	0.086%
5/12/2023	Renaissance Technologies LLC	924,900	$1.35M	0.0%	+9.0%	1.605%
5/12/2023	BlackRock Inc.	3,144,113	$4.59M	0.0%	-2.0%	5.456%
5/12/2023	Bank of America Corp DE	46,149	$67K	0.0%	+20.3%	0.080%
5/12/2023	Charles Schwab Investment Management Inc.	315,931	$0.46M	0.0%	+9.1%	0.548%
5/12/2023	Forefront Analytics LLC	39,295	$57K	0.0%	N/A	0.068%
5/11/2023	Acadian Asset Management LLC	476,297	$0.69M	0.0%	+17.4%	0.826%
5/8/2023	CM Management LLC	180,000	$0.26M	0.3%	+500.0%	0.312%
5/8/2023	Bailard Inc.	27,700	$40K	0.0%	N/A	0.048%
5/4/2023	Barclays PLC	39,687	$58K	0.0%	+46.7%	0.069%
5/3/2023	Privium Fund Management UK Ltd	292,182	$0.46M	0.4%	-20.9%	0.507%
2/15/2023	Jane Street Group LLC	23,561	$38K	0.0%	N/A	0.041%
2/15/2023	Virtu Financial LLC	15,418	$25K	0.0%	N/A	0.027%
2/15/2023	State of Wisconsin Investment Board	145,900	$0.24M	0.0%	-13.3%	0.256%
2/15/2023	Squarepoint Ops LLC	30,218	$49K	0.0%	N/A	0.053%
2/15/2023	Millennium Management LLC	474,354	$0.77M	0.0%	+68.3%	0.834%
2/15/2023	Morgan Stanley	459,667	$0.75M	0.0%	+87.1%	0.808%
2/14/2023	Price T Rowe Associates Inc. MD	163,592	$0.27M	0.0%	-4.4%	0.288%
2/14/2023	Marshall Wace LLP	199,608	$0.32M	0.0%	-17.1%	0.351%
2/14/2023	Two Sigma Investments LP	194,812	$0.32M	0.0%	-19.4%	0.342%
2/13/2023	Charles Schwab Investment Management Inc.	289,515	$0.47M	0.0%	-8.6%	0.509%
2/13/2023	Barclays PLC	27,053	$44K	0.0%	+51.5%	0.048%
2/13/2023	Renaissance Technologies LLC	848,300	$1.37M	0.0%	+21.9%	1.491%
2/13/2023	Pinnacle Wealth Planning Services Inc.	26,206	$42K	0.0%	N/A	0.046%
2/13/2023	Geode Capital Management LLC	742,512	$1.20M	0.0%	+0.9%	1.305%
2/13/2023	GSA Capital Partners LLP	439,926	$0.71M	0.1%	+186.2%	0.773%
2/13/2023	JPMorgan Chase & Co.	2,569,592	$4.16M	0.0%	+0.6%	4.516%
2/10/2023	Bank of America Corp DE	38,374	$62K	0.0%	+103.0%	0.067%
2/10/2023	New York Life Investment Management LLC	78,457	$0.13M	0.0%	+12.7%	0.138%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	25,723	$42K	0.0%	N/A	0.045%
2/9/2023	Privium Fund Management UK Ltd	369,402	$0.60M	0.5%	-42.8%	0.649%
2/9/2023	CM Management LLC	30,000	$49K	0.1%	N/A	0.053%
2/2/2023	Gladius Capital Management LP	20,313	$33K	0.0%	+131.3%	0.036%
1/12/2023	Marquette Asset Management LLC	48,557	$79K	0.0%	N/A	0.085%
12/8/2022	Bank of New York Mellon Corp	133,537	$0.45M	0.0%	+9.2%	0.235%
11/16/2022	Alphabet Inc.	1,438,232	$4.82M	0.2%	N/A	2.528%
11/15/2022	State Street Corp	735,099	$2.46M	0.0%	+2.2%	1.292%
11/15/2022	Algert Global LLC	10,060	$34K	0.0%	N/A	0.018%
11/15/2022	Two Sigma Advisers LP	260,500	$0.87M	0.0%	+31.4%	0.458%
11/15/2022	Two Sigma Investments LP	241,656	$0.81M	0.0%	-33.4%	0.425%
11/15/2022	Vanguard Group Inc.	1,502,584	$5.03M	0.0%	-17.0%	2.641%
11/15/2022	Perceptive Advisors LLC	2,156,151	$7.22M	0.2%	-10.9%	3.790%
11/15/2022	Prelude Capital Management LLC	18,110	$61K	0.0%	N/A	0.032%
11/15/2022	Price T Rowe Associates Inc. MD	171,186	$0.58M	0.0%	-57.1%	0.301%
11/15/2022	Marshall Wace LLP	240,899	$0.81M	0.0%	-31.0%	0.423%
11/15/2022	Federated Hermes Inc.	166,908	$0.56M	0.0%	-41.5%	0.293%
11/15/2022	Bank of New York Mellon Corp	133,537	$0.45M	0.0%	+9.2%	0.235%
11/15/2022	BlackRock Inc.	3,466,420	$11.61M	0.0%	-1.1%	6.092%
11/15/2022	Citadel Advisors LLC	447,283	$1.50M	0.0%	-52.2%	0.786%
11/14/2022	Renaissance Technologies LLC	696,002	$2.33M	0.0%	-13.3%	1.223%
11/14/2022	Nuveen Asset Management LLC	221,044	$0.74M	0.0%	-3.6%	0.388%
11/14/2022	MetLife Investment Management LLC	25,568	$86K	0.0%	N/A	0.045%
11/10/2022	Tower Research Capital LLC TRC	16,964	$57K	0.0%	+412.8%	0.030%
11/3/2022	The Manufacturers Life Insurance Company	14,467	$48K	0.0%	N/A	0.025%
11/1/2022	Privium Fund Management UK Ltd	645,331	$2.16M	2.8%	+50.0%	1.137%
10/31/2022	SG Americas Securities LLC	141,115	$0.47M	0.0%	-4.8%	0.249%
9/16/2022	Federated Hermes Inc.	285,465	$1.04M	0.0%	N/A	0.503%
9/13/2022	Brown Advisory Inc.	38,632	$0.14M	0.0%	N/A	0.068%
8/18/2022	Goldman Sachs Group Inc.	417,242	$1.52M	0.0%	+98.9%	0.735%
8/16/2022	Woodline Partners LP	339,373	$1.24M	0.0%	+77.7%	0.598%
8/16/2022	Casdin Capital LLC	123,839	$0.45M	0.0%	-78.8%	0.218%
8/16/2022	Corton Capital Inc.	13,103	$48K	0.0%	N/A	0.023%
8/16/2022	Delphia USA Inc.	14,256	$52K	0.0%	N/A	0.025%
8/15/2022	Occudo Quantitative Strategies LP	74,161	$0.27M	0.0%	N/A	0.131%
8/15/2022	AQR Capital Management LLC	56,714	$0.21M	0.0%	N/A	0.100%
8/15/2022	State Street Corp	719,529	$2.62M	0.0%	-62.6%	1.267%

Data available starting January 2016

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial; and Lanraplenib, a next-generation SYK inhibitor to treat the patients with relapsed/refractory FLT3-mutated acute myeloid leukemia. The company was incorporated in 2017 and is headquartered in San Mateo, California.

Today's Range

Now: $1.18

$1.18

$1.25

50 Day Range

MA: $1.06

$0.75

$1.30

52 Week Range

Now: $1.18

$0.73

$2.84

Volume

64,823 shs

Average Volume

298,132 shs

Market Capitalization

$68.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Who are the company insiders with the largest holdings of Kronos Bio?: Kronos Bio's top insider investors include:
Norbert W Bischofberger (CEO)
Yasir B Al-Wakeel (CFO)
Jorge Dimartino (VP)
Christopher Dinsmore (Insider)
Backer Marianne De (Director)
Learn More about top insider investors at Kronos Bio.
Who are the major institutional investors of Kronos Bio?: Kronos Bio's top institutional investors include:
Acuta Capital Partners LLC — 1.23%
Acadian Asset Management LLC — 1.05%
GSA Capital Partners LLP — 0.09%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Kronos Bio stock.
Which major investors are selling Kronos Bio stock?: In the last quarter, KRON stock was sold by these institutional investors:
GSA Capital Partners LLP
Within the last year, company insiders that have sold Kronos Bio company stock include:
Norbert W Bischofberger (CEO)
Yasir B Al-Wakeel (CFO)
Jorge Dimartino (VP)
Learn More investors selling Kronos Bio stock.
Which major investors are buying Kronos Bio stock?: During the last quarter, KRON stock was bought by institutional investors including:
Acuta Capital Partners LLC
Acadian Asset Management LLC
In the previous year, these company insiders have bought Kronos Bio stock:
Norbert W Bischofberger (CEO)
Yasir B Al-Wakeel (CFO)
Learn More investors buying Kronos Bio stock.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

KRON Insider Trading

Kronos Bio Insider Trading History Chart

Kronos Bio Share Price & Price History

Kronos Bio Insider Trading History

SEC Filings (Institutional Ownership Changes) for Kronos Bio (NASDAQ:KRON)

Institutional Buying and Selling by Quarter

Kronos Bio Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Kronos Bio?

Who are the major institutional investors of Kronos Bio?

Which major investors are selling Kronos Bio stock?

Which major investors are buying Kronos Bio stock?